US Broker Ratings

Labcorp Holdings Inc. (LH) Investor Outlook: Assessing the 13.45% Potential Upside

Labcorp Holdings Inc. (NYSE: LH), a major player in the Healthcare sector, specifically in Diagnostics & Research, presents a compelling case for investors looking to tap..

Veeva Systems Inc. (VEEV) Stock Analysis: 41% Potential Upside Captures Investor Attention

Veeva Systems Inc. (NYSE: VEEV), a leading provider of cloud-based solutions for the life sciences sector, is currently a focal point for investors eyeing significant upside..

Takeda Pharmaceutical Company L (TAK): Investor Outlook as Analysts See 22.75% Upside Potential

For individual investors with an eye on the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents a compelling opportunity. As a leading player in the..

IDEXX Laboratories, Inc. (IDXX) Growth Potential: A Deep Dive into its 8.78% Upside and Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the Healthcare sector under the Diagnostics & Research industry, has captured investor attention with its significant market..

Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 21.3% Upside Potential in Diagnostics & Research

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, stands out with a market capitalization of $39.6 billion and a promising upside potential..

Johnson & Johnson (JNJ) Stock Analysis: Navigating Growth in Healthcare with a 33.62% ROE

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to capture investor attention with its substantial market cap of $509.76 billion and its..

ResMed Inc. (RMD) Stock Analysis: A 16.59% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a formidable player in the healthcare sector, stands out with a market capitalization of $36.82 billion. Specializing in medical instruments and supplies,..

DexCom, Inc. (DXCM) Stock Analysis: 26.71% Potential Upside Sparks Investor Interest

DexCom, Inc. (NASDAQ: DXCM) continues to capture the attention of investors with its promising growth trajectory and robust product offerings in the medical device sector, specifically..

Boston Scientific Corporation (BSX): Investor Outlook with a 36.62% Upside Potential

Boston Scientific Corporation (NYSE: BSX), a titan in the medical devices industry, is catching the eye of investors with its substantial market capitalization of $137.24 billion..

GSK plc (GSK) Stock Analysis: A Healthcare Giant with Stable Growth and Dividend Appeal

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, stands as one of the prominent players in the drug manufacturing industry. With a market capitalization..

AstraZeneca PLC (AZN) Stock Analysis: Discover the 10.16% Upside Potential and Strong Buy Ratings

AstraZeneca PLC (NASDAQ: AZN), a global leader in the healthcare sector, has caught the attention of investors with its robust market presence and promising future outlook...

Thermo Fisher Scientific (TMO): Robust Analyst Consensus and Solid Growth Potential

Thermo Fisher Scientific Inc. (NYSE: TMO) stands out in the healthcare sector as a formidable entity within the diagnostics and research industry. With a staggering market..

UnitedHealth Group Incorporated (UNH) Stock Analysis: A Look at Its 14.74% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, presents an intriguing opportunity for investors. With a substantial market capitalization of $309.65 billion, the..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a Remarkable 8.45% Upside Potential

Elevance Health, Inc. (NYSE: ELV) stands as a formidable player in the healthcare sector, specifically within the healthcare plans industry. With a substantial market capitalization of..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring the 87.97% Upside Potential

Investors with a keen eye on the healthcare sector might find Treace Medical Concepts, Inc. (NASDAQ: TMCI) an intriguing opportunity, especially in light of its impressive..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Growth Challenges with Strategic Alliances

Investors eyeing the healthcare sector might find Myriad Genetics, Inc. (NASDAQ: MYGN) a compelling yet complex prospect. As a leader in molecular diagnostic testing and precision..

AngioDynamics, Inc. (ANGO) Poised for Growth: 44% Upside Potential Amid Robust Analyst Ratings

AngioDynamics, Inc. (ANGO), a key player in the healthcare sector, is drawing significant attention from individual investors, thanks to a compelling 43.85% upside potential as suggested..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Robust Potential Upside Amid Healthcare Challenges

Emergent BioSolutions Inc. (NYSE: EBS) presents an intriguing opportunity for investors, particularly in the healthcare sector. With a current market capitalization of $625.27 million, this Gaithersburg,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds